Clinical Trial Update: Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma [NA]

View source ↗

Summary

Terminated clinical trial evaluating an immunotoxin on activated human macrophages in individuals with allergic rhinitis or mild intermittent asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Immunotoxin

Snippet

Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine | Conditions: Atopy, Rhinitis | NA | Status: TERMINATED